Send to

Choose Destination
See comment in PubMed Commons below
Oncoimmunology. 2012 Dec 1;1(9):1650-1651.

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer.

Author information

Department of Medicine; UCLA Lung Cancer Research Program; David Geffen School of Medicine; University of California at Los Angeles; Los Angeles, CA USA ; Molecular Gene Medicine Laboratory; Veterans Affairs Greater Los Angeles Healthcare System; Los Angeles, CA USA.


Myeloid-derived suppressor cells (MDSCs) are important regulators of immune responses. These cells suppress the cytotoxic activities of natural killer (NK)-cell and T-cell effectors and promote tumor growth. We demonstrated that depleting MDSCs improve therapeutic responses to vaccination in a murine model of lung cancer. This approach may prove beneficial against tumors in which MDSC exert prominent immunosuppressive effects.

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center